AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

The LinkedIn founder talks about his new book, ‘Superagency,’ and argues that people can use AI to reshape their daily work lives.

Plus: Caroline Kennedy calls Robert F. Kennedy Jr. a predator ahead of his confirmation hearing | State Dept. allows HIV meds ...

Reid Hoffman, Greylock partner, Inflection AI and LinkedIn co-founder, and ‘Superagency' author, joins 'Squawk Box' to ...

Dedicated to spotlighting global leaders, the Tarnopol series serves as a platform for addressing critical societal issues, ...

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...

Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.

LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new ...

LinkedIn co-founder and AI investor Reid Hoffman argues we shouldn't be afraid of AI or its disruptive capabilities in his ...

LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in ...

OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...